Shares of IPCA Laboratories have yielded a return of 8 per cent in the last six months and nearly 30 per cent in the last one ...

Ipca Laboratories Ltd. is a Public Limited Listed company incorporated on 19/10/1949 and has its registered office in the State of Maharashtra, India. Company's Corporate Identification Number(CIN) is ...

The P/B ratio shows how a stock's market price compares to its book value. It helps gauge whether a stock is undervalued or overvalued relative to its net assets.

has now become wholly owned subsidiary of Ipca Laboratories (U.K.) Ltd. which in turn is the wholly owned subsidiary of the Company.During the year 2018, the Company acquired 100% share capital of ...

The pharma company's revenue rose 9% on-year to ₹2,245.4 crore during the quarter. Indian formulations income surged 13% to ...

IPCA Lab said its consolidated net profit grew 38 percent year-on-year to Rs 248 crore in the December quarter. The drug firm ...

IPCA Laboratories Ltd.'s share price inched towards day's high after the company reported a 39% on the year rise in its consolidated net profit. Its third-quarter net profit stands at Rs 248 crore ...

Prabhudas Lilladher recommended accumulate rating on Ipca Laboratories with a target price of Rs 1700 in its research report ...

Ipca Laboratories Ltd (BOM:524494) reported a 13% growth in its domestic formulation business for the quarter. The company's market share improved by 11 basis points, reaching 2.05% in the current ...

The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...

Motilal Oswal Financial Services recommends buying Ipca Laboratories with a target price of Rs 1980. The company reported strong quarterly financial growth, with a rise in total income and net profit.